ESR1 and breast neoplasm: Postmenopausal breast cancer risk overall and by estrogen receptor (ER) and progesterone receptor (PR) status of breast tumors and changes in physical activity (PA) level among 1,767 breast cancer cases in the Norwegian Women and Cancer Study